Treatment of pancreatic pseudocysts with octreotide

Lancet. 1991 Aug 31;338(8766):540-1. doi: 10.1016/0140-6736(91)91102-z.

Abstract

Pancreatic pseudocysts are a common and painful complication of chronic pancreatitis. Seven patients (six male, one female; mean age 49.9 years) with chronic pancreatitis complicated by pseudocysts and persistent pain were treated with the pancreatic anti-secretory drug octreotide for 2 weeks. Octreotide caused no notable changes in the size of the pseudocysts of three patients. In the remaining four patients, the pseudocysts decreased in size by a mean of 42% (range 29-52%), and pain disappeared completely. These findings suggest a role for octreotide in the treatment of pancreatic pseudocysts.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aged
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Follow-Up Studies
  • Humans
  • Injections, Subcutaneous
  • Male
  • Middle Aged
  • Octreotide / administration & dosage
  • Octreotide / therapeutic use*
  • Pain / drug therapy
  • Pain / etiology
  • Pancreatic Pseudocyst / drug therapy*
  • Pancreatic Pseudocyst / etiology
  • Pancreatitis / complications
  • Recurrence

Substances

  • Octreotide